Sector: Pharmaceuticals & Biotechnology

Small Cap

Concord Drugs Share Price

Concord Drugs Ltd.

₹76.40

1.21(1.61%)

25th Jun 2026 | 3:15 PM

NSE :

Open Free Demat Account

Concord Drugs Performance

Price Movement

N/A

₹75.00

₹76.99

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹76.99

Low₹75.00

Open at₹75.19

Prev Close₹75.19

Volumes4.02 K

Avg Price₹75.58

Lower Circuit₹61.07

Upper Circuit₹91.59

Historical Performance

3M High₹89.00

3M Low₹68.00

1 Yr High₹92.52

1 Yr Low₹30.51

3 Yr High₹92.52

3 Yr Low₹25.56

5 Yr High₹92.52

5 Yr Low₹19.50

Summary

As of 26-06-2026 04:33, Concord Drugs Ltd. share price today is ₹0, with a change of ₹-75.19 (-100.00%) from the previous close of ₹75.19. The stock opened at ₹75.19 and traded between ₹75 and ₹76.99, with a total traded volume of 4018 shares. The company has a market capitalization of ₹100.7 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹92.52 and ₹29.55, respectively.

Concord Drugs Ltd. valuation metrics include a P/E ratio of 95.4, EPS of ₹0.95, and book value of ₹2.10. Profitability indicators show ROE of 2.17%. Concord Drugs Ltd. has reported revenue of ₹78.74 Cr and net profit of ₹1.06 Cr.

Concord Drugs Ltd. technical indicators include Day RSI at 43.49, Day MFI at 18.84, Day ADX at 15.63. Additional indicators include Commodity Channel Index (CCI) at -121.7 and Williams %R at -78.22. Momentum indicators show Day MACD at -1.28, Day MACD Signal Line at -0.86, DayATR at 4.5. Rate of Change indicators for Concord Drugs Ltd. include ROC125 at -8.73 and ROC21 at -6.66.

Exponential moving averages include EMA5 at ₹76.4, EMA10 at ₹77.2, EMA12 at ₹77.5, EMA20 at ₹78.4, EMA26 at ₹78.8, EMA50 at ₹79.3, EMA100 at ₹78.4, EMA200 at ₹73.4. Simple moving averages include SMA5 at ₹76.2, SMA10 at ₹77.4, SMA20 at ₹79.2, SMA30 at ₹79.5, SMA50 at ₹81.2, SMA100 at ₹78.7, SMA150 at ₹79.6, SMA200 at ₹76.9.

Support levels for Concord Drugs are placed at First Support ₹75.22, Second Support ₹74.12, Third Support ₹73.23. Resistance levels are seen at First Resistance ₹77.21, Second Resistance ₹78.10, Third Resistance ₹79.20. Concord Drugs Ltd. shareholding pattern shows promoter holding at 54.39%, FII holding at 0%, DII holding at 0%, public holding at 45.61%.

Concord Drugs Fundamentals

Market Cap

Below industry Median

100.70 Cr.

PE Ratio (TTM)

High in industry

95.40

Dividend Yield

Net Profit TTM

211.8% incr over last year

1.06

Net Profit Growth

211.8% incr over last year

1.06

PEG Ratio

Above industry Median

0.40

ROE

121.4% incr over last year

2.17

Operating Revenue TTM

78.74

Operating Revenue Growth

74.1% incr over last year

Book Value

Below industry Median

2.10

MFI

MFI strongly Oversold

18.84

RSI

RSI is mid-range

43.49

EPS (TTM)

0.95

Debt to Equity

0.28

Face Value

Operating Profit Margin Qtr.

5.74

Operating Profit Qtr.

1.49

Net Profit Qtr.

0.53

Operating Revenue Qtr.

37.89

PB Ratio

2.10

Concord Drugs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	35.55	16.84	10.07	13.38	7.96
Operating Expense	34.13	15.97	9.21	12.45	7.04
Operating Profit	1.42	0.87	0.87	0.94	0.92
Depreciation	0.35	0.30	0.34	0.37	0.37
Interest	0.34	0.30	0.40	0.42	0.53
Tax	0.22	0.08	0.04	0.04	0.01
Net Profit	0.52	0.22	0.09	0.11	0.01

Concord Drugs Technicals

Concord Drugs Ltd. EMA & SMA

₹76.40

1.21 (1.61%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹76.4

Day EMA10 ₹77.2

Day EMA12 ₹77.5

Day EMA20 ₹78.4

Day EMA26 ₹78.8

Day EMA50 ₹79.3

Day EMA100 ₹78.4

Day EMA200 ₹73.4

Concord Drugs Support and Resistance

Resistance

First Resistance₹77.21

Second Resistance₹78.10

Third Resistance₹79.20

Support

First Support₹75.22

Second Support₹74.12

Third Support₹73.23

Technical Indicators

Day RSI43.49

Day MFI18.84

Day ADX15.63

Day Commodity Channel Index-121.70

William-78.22

Day MACD-1.28

Day MACD Signal Line-0.86

Day ATR4.50

Day ROC125-8.73

Day ROC21-6.66

Concord Drugs Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	54.4	54.4	54.4	54.4	54.4	54.4
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	45.6	45.6	45.6	45.6	45.6	45.6

Concord Drugs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2.61 K	4.02 K	64.98%
Week	3.85 K	5.77 K	66.75%
1 Month	4.22 K	5.75 K	73.44%
6 Month	5.6 K	7.27 K	77.02%

Concord Drugs SWOT Analysis

Strengths16

Weakness6

Opportunity0

Threats0

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Consistent high performing stocks over Five Years

Mid-range Performer (DVM)

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 4 quarters

Increasing Revenue every quarter for the past 2 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Top Gainers

Concord Drugs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Concord Drugs Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹43.20	₹588	₹201	₹258.80	₹35.50	₹5.70
% Change	-3.76%	-0.30%	-1.95%	-2.34%	-1.33%	-1.04%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	10.10	-	13.50	37.00	-84.00	-1.40
1 Year Return		49.31			688.89	471
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 235.15

+0.73%

AMANTA

Amanta Healthcare Ltd.

₹ 162.00

-0.52%

AHCL

Anlon Healthcare Ltd.

₹ 16.37

+1.49%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 93.60

+1.15%

APL

Asston Pharmaceuticals Ltd.

₹ 81.00

-1.22%

UNICHEMLAB

Unichem Laboratories Ltd.

₹ 432.60

-0.22%

FERMENTA

Fermenta Biotech Ltd.

₹ 364.25

-0.26%

GENPHARMA

Genpharmasec Ltd.

₹ 1.11

-2.63%

KILITCH

Kilitch Drugs(I) Ltd.

₹ 185.00

-3.05%

MEDICO

Medico Remedies Ltd.

₹ 40.00

-2.56%

PHARMAID

Pharmaids Pharmaceuticals Ltd.

₹ 36.00

+4.93%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 305.80

-1.61%

KIMIABL

Kimia Biosciences Ltd.

₹ 33.74

+4.88%

CORALAB

Coral Laboratories Ltd.

₹ 625.00

-3.52%

JENBURPH

Jenburkt Pharmaceuticals Ltd.

₹ 1126.60

-0.13%

KPL

Kwality Pharmaceuticals Ltd.

₹ 2436.70

-0.54%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 228.00

-0.61%

GVBL

Genomic Valley Biotech Ltd.

₹ 33.36

-4.98%

UNJHAFOR

Unjha Formulations Ltd.

₹ 19.00

+0.00%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.48

-0.52%

ANG

ANG Lifesciences India Ltd.

₹ 42.21

+1.93%

BROOKS

Brooks Laboratories Ltd.

₹ 73.20

-4.69%

FAQ's on CONCORD

What is the Market Capitalization of Concord Drugs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Concord Drugs Ltd. is approximately ₹ 100.7 Cr.

What are the PE and PB ratios for Concord Drugs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Concord Drugs Ltd. is 95.4, and the Price-to-Book (PB) ratio is 2.1.

What is the 52-Week High and Low for Concord Drugs Ltd.?

Over the past 52 weeks, the highest price reached by Concord Drugs Ltd. shares was ₹ 92.52, and the lowest price was ₹ 30.51.

Who are the major shareholders of Concord Drugs Ltd.?

Significant shareholdings in Concord Drugs Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Concord Drugs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Concord Drugs Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy